NASDAQ:CRSP

Crispr Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CRSP

*Your capital is at risk

$52.08

+0.0600 (+0.115%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CRSP Prediction Chart

CRSP Predictions History

Latest community submissions for CRSP.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 6, 2019	$40.97 -2.66%	$42.09	X	97.34%	0
GoldenNugget Pro	May 6, 2019	$39.66 -5.78%	$42.09	X	94.22%	0
NameNotImportant Pro	May 3, 2019	$39.99 -1.43%	$40.57	X	98.57%	1
NameNotImportant Pro	Apr 29, 2019	$39.16 -2.78%	$40.28	X	97.22%	0
JS Pro	May 15, 2018	$55.48 -3.93%	$57.75	X	96.10%	0
amiknyc	May 15, 2018	$54.50 -5.63%	$57.75	X	94.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRSP with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CRISPR THERAPEUTICS AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by